The primary objective of this collaborative double-blind placebo- controlled trial is to determine, using a factorial design, whether aspirin (324 mg/day) or lovastatin (20-40 mg/day), over an average treatment period of three years, retards the progression of atherosclerotic plaques in the carotid arteries of high risk individuals with asymptomatic carotid stenosis. Men and women free of clinically evident coronary and cerebrovascualr disease who are 50 years of age or older, with total serum cholesterol levels between approximately the 50th (220 mg/dl) and 90th (260 mg/dl) percentiles and at least one plaque with a thickness between 1.0 and 4.0 mm are eligible for participation. A secondary objective is to determine the safety of long-term therapy with the two active interventions, individually and in combination. Coronary and cerebrovascular events will be monitored and natural history studies conducted. Progression of the atherosclerotic lesions will be determined semi-annually. Mean wall thickness from the far wall of the carotid artery (common, bifurcation and internal) will be the primary outcome measure. Maximum wall thickness/minimum lumen diameter will also be determined as well as a global extent score. The goal of the lipid-lowering treatment is to bring total serum cholesterol below 180 mg/dl. A favorable outcome of the trial will have major public health implications for the prevention/control of atherosclerosis and its complications. The successful employment of B-mode imaging will greatly impact on health care (ability to monitor plaque progression non-invasively in individuals) and permit a reduction in cost and time for future clinical trials evaluating treatment for atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL038194-02
Application #
3354287
Study Section
Clinical Trials Review Committee (CLTR)
Project Start
1988-05-01
Project End
1993-04-30
Budget Start
1989-05-26
Budget End
1990-04-30
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Byington, R P; Evans, G W; Espeland, M A et al. (1999) Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 100:e14-7
Espeland, M A; Craven, T E; Miller, M E et al. (1999) 1996 Remington lecture: modeling multivariate longitudinal data that are incomplete. Ann Epidemiol 9:196-205
Riley, W A; Craven, T; Romont, A et al. (1996) Assessment of temporal bias in longitudinal measurements of carotid intimal-medial thickness in the Asymptomatic Carotid Artery Progression Study (ACAPS). ACAPS Research Group. Ultrasound Med Biol 22:405-11
Espeland, M A; Applegate, W; Furberg, C D et al. (1995) Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Am J Epidemiol 142:1011-9
Espeland, M A; Hoen, H; Byington, R et al. (1994) Spatial distribution of carotid intimal-medial thickness as measured by B-mode ultrasonography. Stroke 25:1812-9
Furberg, C D; Adams Jr, H P; Applegate, W B et al. (1994) Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 90:1679-87
Probstfield, J L; Byington, R P; Egan, D A et al. (1993) Methodological issues facing studies of atherosclerotic change. Circulation 87:II74-81
Espeland, M A; Byington, R P; Hire, D et al. (1992) Analysis strategies for serial multivariate ultrasonographic data that are incomplete. Stat Med 11:1041-56
(1992) Rationale and design for the Asymptomatic Carotid Artery Plaque Study (ACAPS). The ACAPS Group. Control Clin Trials 13:293-314
Riley, W A; Barnes, R W; Applegate, W B et al. (1992) Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study. Stroke 23:1062-8